Global Mitotane Market 2023: Rising Demand for Adjuvant Therapy Offers Impetus

Mitotane is a medication used in the treatment of advanced adrenocortical carcinoma (ACC), a rare and aggressive cancer that affects the outer layer of the adrenal gland. Mitotane is used as a first-line therapy for ACC and it is believed to work by inhibiting the synthesis of steroid hormones. The market for Mitotane is relatively small due to the rarity of ACC. The market is expected to grow due to the increasing incidence of ACC and the growing use of Mitotane in the treatment of this disease. However, the high cost of Mitotane and the lack of alternative therapies may limit market growth. The Mitotane market is also regulated and controlled by few companies, which can also limit the market growth.

Request For Free Sample Report of "Mitotane Market"@ https://www.persistencemarketresearch.com/samples/30052

The ~US$ 12 billion market for mitotane is anticipated to grow at a healthy CAGR over the period of next decade. Macro-economic factors, such increase expenditure in healthcare sector in emerging nations such as China, India, and Brazil is expected to boost the growth of the mitotane market in the forecast period. With the rise and continual growth in global healthcare expenditure, sales of pharma drugs such as mitotane in countries outside the U.S. represent a potential growth avenue for domestic manufacturers.

According to the World Bank, all regions (except Sub-Saharan Africa) have seen an increase in the healthcare spending as a percentage of total output over the last two decades. Similarly, in 2016, China's healthcare expenditure grew ~5% of the GDP, which is expected to almost double by 2020.

The market for mitotane is based on two disease indications such as Cushing's syndrome and ACC. Cushing's syndrome includes symptoms such as round red face, high blood pressure, weak muscles and bones, abdominal obesity, a fat lump between shoulders, and fragile skin. The prevalence rate varies from 10-15 cases/ million population/year. High disease diagnosis screening percentage and attractive reimbursement in developed markets have made the mitotane market to grow significantly.

Companies

HRA Pharma
Bristol-Myers Squibb Company

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/30052

In contrast, ACC is a rare but aggressive tumour that arises from adrenal cortex and develops late with a large mass. It is estimated that ~600 new cases are diagnosed every year/million population. The disease is most common between 50 and 60 years of age. According to PMR, ACC-based disease indication is anticipated to hold a prominent position in the global mitotane market, in terms of revenue with a global market share of ~60% in 2029.

Major players in the mitotane market are focusing on investing in research and development for the improvement of mitotane with less side effects, and introduction of more affordable and reliable drug treatments in developing regions of the world. Besides, companies are also engaged in commercial partnerships for the sales and marketing of mitotane. Such developments are likely to foster the market to grow in untapped regions and meet the treatment demand.

The mitotane market report offers a comprehensive taxonomy based on the disease indication, distribution channel, and region. Based on disease indication, the global mitotane market is segmented into ACC and Cushing's syndrome.

Based on distribution channel, the mitotane market is classified into hospital pharmacies, retail pharmacies, online pharmacies, and specialty clinics. With the increase in the incidence of both the diseases and growth opportunities in terms of sales, the mitotane market also offers significant potential for other players to invest in the market.

The mitotane market has been studied across North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA, and Emerging countries such as China, Brazil, and India. Availability of knowledge-based resources and enhanced research collaboration trends in North America and Europe are estimated to propel the growth of the mitotane market. North America and Europe markets are projected to be the prominent regional markets for mitotane and are poised to offer substantial opportunities.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/30052

Key Questions Answered in This Report.

What are the Roadblocks for Mitotane Market Suppliers?
What are the Key Opportunities for Mitotane Market Manufacturers?
How is Focus on Safety Influencing Mitotane Market Demand?
What is the Regulatory Impact on Global Sales of Mitotane Market?
Which Region Offers the Largest Opportunity for Sales of Mitotane Market?
Where Does the U.S. Stand in the Market for Mitotane Market?
What Is the Outlook for Mitotane Market Manufacturers in China?
Why is Germany a Lucrative Market for Mitotane Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Mitotane Market?
Why is There High Demand for Tires in Mitotane Market?
Why are Sales of Mitotane Market Surging?

For More Premium Insights, Check out the Link:

Botulinum Toxin Market -https://www.prnewswire.com/news-releases/botulinum-toxin-market-is-set-to-expand-at-a-cagr-of-6-9-and-reach-a-valuation-of-us-10-7-bn-by-2031--301477267.html

Psoriasis Drugs Market -https://www.prnewswire.com/news-releases/psoriasis-drugs-market-is-predicted-to-progress-at-a-cagr-of-6-5-to-reach-a-valuation-of-us-21-48-bn-by-2031--301482350.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.